Dare Bioscience DARE
NASDAQ DARE
$0.85 +0.04 (+4.94%)
At close: Sep 30, 2026 · 4:00 PM EDT

Dare Bioscience (DARE) Change in Receivables (2016 - 2024)

Updated

Dare Bioscience (DARE) posted Change in Receivables of $12,053 for FY2025.

Analysis

Dare Bioscience (DARE) Change in Receivables (2016 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Dare Bioscience 12.89 Mn -52.57 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -39,665.00
Mar 31, 2024 67,644.00
Mar 31, 2017 316,000.00
Mar 31, 2016 18,000.00
API Access

Dare Bioscience Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=DARE&period=max&api_key=YOUR_API_KEY